NEW YORK (Reuters Health) – Intensive insulin therapy in type 1 diabetics reduces their risks of neuropathy and retinopathy over the long-term, according to two papers published online…
Joseph Demer, MD, Professor of Opthalmology and Neurology, UCLA David Geffen School of Medicine, discusses lateral rectus ligament dysfunction in the eye, its diagnosis and management techniques used…
Joseph Demer, MD, Professor of Opthalmology and Neurology, UCLA David Geffen School of Medicine, discusses eye muscles, which are regulated by connective tissue structures called pulleys, and horizontal…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses uveal melanoma treatment which depends on saving the patient’s life before consideration of saving the eye…
Joseph Demer, MD, Professor of Opthalmology and Neurology, UCLA David Geffen School of Medicine, discusses double vision, which is not uncommon in the elderly and is traditionally attributed…
NEW YORK (Reuters Health) – New research indicates that operative times are independently and directly linked to the risk of infectious complications and the length of hospital stay.…
Robert Goldberg, MD, Chief, Orbital and Opthalmic Plastic Surgery, David Geffen School of Medicine UCLA, discusses new advances on the medical and surgical sides of Graves’ Eye Disease,…
NEW YORK (Reuters Health) – New research suggests that fluoroquinolones may cause diplopia in some patients. “According to World Health Organization criteria, the relationship between fluoroquinolone therapy and…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Director of Oculoplastics and Orbital Surgery, Yale University, discusses losing an eye due to trauma, cancer, etc, and what…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Director of Oculoplastics and Orbital Surgery, Yale University, discusses cosmeceuticals such as Latisse used for eyelash growth. Summary: Latisse…